<DOC>
	<DOCNO>NCT01462383</DOCNO>
	<brief_summary>Primary Objective : -Evaluate incidence cardiac complication Phase I patient . Secondary Objective : -To identify variable ( i.e . number electrocardiogram ( EKG ) perform ) lead detection cardiac event .</brief_summary>
	<brief_title>The Role EKG Anticancer Drug Development</brief_title>
	<detailed_description>The research plan include retrospective review chart past UT MD Anderson Cancer Center ( MDACC ) patient experience treat . All study analyze Phase I clinical trial . Analysis design collect information number timeframe within ECGs perform trial . Data adverse event serious adverse event , dose modification base ECG change , attribution drug , incidence type ECG change specifically QTC prolongation well influence study procedure like dose limit toxicity ( DLTs ) dose escalation phase study . Study conduct use clinical record patient treat Phase I protocols MDACC Department Investigational Cancer Therapeutics . The demographic data collect patient whose chart analyze include variable age , gender , primary cancer , stage disease , performance status , treatment characteristic ( i.e. , number type prior therapy ) , disease status , adverse event , laboratory data ( i.e. , complete blood count/differential/platelets , tumor marker ) , treatment outcome . The analysis allow identification descriptive analysis occurrence cardiac event phase I population help define role protocol require EKGs detection . HIPAA privacy confidentiality guideline follow . The database secure Department server . A Data coordinator recruit undertake project . The information derive observation help investigator formulate research question project develop future prospective study . The statistical analysis perform descriptive fashion pair multivariable analysis . The analysis report use summary table , figure , data listing . Continuous variable summarize use mean , standard deviation , median , minimum , maximum . This study conduct MD Anderson Cancer Center Houston , Texas .</detailed_description>
	<criteria>All type advance cancer</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Advanced Cancer</keyword>
	<keyword>Malignancy</keyword>
	<keyword>Cardiac complication</keyword>
	<keyword>Electrocardiograms</keyword>
	<keyword>ECG</keyword>
	<keyword>Chart Review</keyword>
	<keyword>Data Review</keyword>
	<keyword>Data Analysis</keyword>
	<keyword>Phase I</keyword>
	<keyword>Clinical Research Study</keyword>
</DOC>